HUTCHMED (SEHK:13) Announces Vesting of LTIP Awards

Bulletin Express
Oct 21

On October 21, 2025, HUTCHMED (China) Limited published an announcement regarding the vesting of certain non-performance based awards granted on October 20, 2021, under its Long Term Incentive Plan. According to the announcement, the awards vested on October 20, 2025.

The directors named in the announcement—Non-executive Director Dr. Dan Eldar, Non-executive Director Ms. Edith Shih, and Independent Non-executive Director Professor Tony Mok—each received 1,938 American depositary shares (ADS). For Ms. Shih, the ADS were issued to her employer, Hutchison International Limited. HUTCHMED is a commercial-stage biopharmaceutical company focused on targeted therapies and immunotherapies for cancer and immunological diseases. Further details appear in the official announcement dated October 21, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10